These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31217523)

  • 21. Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia.
    Cara AKS; Zaidi STR; Suleman F
    Int J Clin Pharm; 2018 Oct; 40(5):1051-1058. PubMed ID: 30117080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia.
    Elefritz JL; Bauer KA; Jones C; Mangino JE; Porter K; Murphy CV
    J Intensive Care Med; 2017 Sep; 32(8):487-493. PubMed ID: 27139010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.
    Horcajada JP; Sorlí L; Luque S; Benito N; Segura C; Campillo N; Montero M; Esteve E; Mirelis B; Pomar V; Cuquet J; Martí C; Garro P; Grau S
    Int J Antimicrob Agents; 2016 Dec; 48(6):725-727. PubMed ID: 28128096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and nephrotoxicity associated with colistin use in an intensive care unit in Vietnam: Use of colistin in a population of lower body weight.
    Binh NG; Hayakawa K; Co DX; Tuan ND; Anh NH; Thuy NT; Phuong DM; Huong NT; Thuy PT; Chau NQ; Nhung PH; Gam do TH; Hai DT; Huong TT; Van Anh L; Takeshita N; Ohmagari N
    Int J Infect Dis; 2015 Jun; 35():18-23. PubMed ID: 25835100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of Effectiveness and Safety of Colistin for Therapy in Resistant Gram-Negative Bacterial Infections in Hospitalized Patients at Siriraj Hospital.
    Thamlikitkul V; Popum S
    J Med Assoc Thai; 2016 Mar; 99(3):301-7. PubMed ID: 27276741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergent renal dysfunction with colistin pharmacotherapy.
    Collins JM; Haynes K; Gallagher JC
    Pharmacotherapy; 2013 Aug; 33(8):812-6. PubMed ID: 23606349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing colistin dosing: Is a loading dose necessary?
    Nazer LH; Anabtawi N
    Am J Health Syst Pharm; 2017 Jan; 74(1):e9-e16. PubMed ID: 28007716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotoxicity associated with intravenous colistin in critically ill patients.
    Doshi NM; Mount KL; Murphy CV
    Pharmacotherapy; 2011 Dec; 31(12):1257-64. PubMed ID: 22122186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
    Katip W; Uitrakul S; Oberdorfer P
    Int J Infect Dis; 2020 Aug; 97():391-395. PubMed ID: 32502665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
    Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
    Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection.
    Lam SW; Athans V
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance.
    Aitullina A; Krūmiņa A; Svirskis Š; Purviņa S
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30709064
    [No Abstract]   [Full Text] [Related]  

  • 35. Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction.
    Turkoglu M; Dizbay M; Ciftçi A; Aksakal FN; Aygencel G
    Int J Antimicrob Agents; 2012 Feb; 39(2):142-5. PubMed ID: 22115538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
    Sorlí L; Luque S; Segura C; Campillo N; Montero M; Esteve E; Herrera S; Benito N; Alvarez-Lerma F; Grau S; Horcajada JP
    BMC Infect Dis; 2017 Jan; 17(1):11. PubMed ID: 28056821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
    Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
    Falagas ME; Sideri G; Korbila IP; Vouloumanou EK; Papadatos JH; Kafetzis DA
    Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study.
    Wacharachaisurapol N; Sukkummee W; Anunsittichai O; Srisan P; Sangkhamal S; Chantharit P; Vandepitte WP; Wattanavijitkul T; Puthanakit T
    Int J Infect Dis; 2021 Aug; 109():230-237. PubMed ID: 34192578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.